Efficacy and cost-benefit analysis of risk-adaptive use of plerixafor for autologous hematopoietic progenitor cell mobilization
Prakash Vishnu, Vivek Roy, Athena Paulsen, Abba C. ZubairVolume:
52
Year:
2012
Language:
english
Pages:
8
DOI:
10.1111/j.1537-2995.2011.03206.x
File:
PDF, 213 KB
english, 2012